Patents by Inventor Mark Dunnett

Mark Dunnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10881629
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: January 5, 2021
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20190038583
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: February 27, 2018
    Publication date: February 7, 2019
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 9907770
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: March 6, 2018
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20170202796
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 9668994
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: June 6, 2017
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20160051502
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: March 30, 2015
    Publication date: February 25, 2016
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 8993610
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: March 31, 2015
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20130261336
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: May 22, 2013
    Publication date: October 3, 2013
    Applicant: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 8470865
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: June 25, 2013
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20120190717
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Applicant: Natural Alternatives Internatioal, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 8129422
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: March 6, 2012
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20110312882
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 22, 2011
    Applicant: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 8067381
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: November 29, 2011
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20110009346
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: August 10, 2010
    Publication date: January 13, 2011
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 7825084
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: November 2, 2010
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 7504376
    Abstract: The invention provides compositions comprising beta-alanylhistidine peptides and beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: March 17, 2009
    Assignee: Natural Alternatives International
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20090005293
    Abstract: Provided are compositions comprising beta-alanylhistidine peptides and beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: August 29, 2008
    Publication date: January 1, 2009
    Inventors: Roger Harris, Mark Dunnett
  • Publication number: 20040229773
    Abstract: The invention provides compositions comprising beta-alanylhistidine peptides and beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
    Type: Application
    Filed: November 18, 2003
    Publication date: November 18, 2004
    Applicant: NATURAL ALTERNATIVES INTERNATIONAL
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: 6680294
    Abstract: A method for increasing the synthesis and accumulation of beta-alanylhistidine dipeptides, with a simultaneous increase in the accumulation of creatine, in bodily tissues of humans and animals is described. This is accomplished by causing an increase in the blood plasma concentrations of beta-alanine and creatine, or the blood plasma concentrations of beta-alanine, L-histidine and creatine, by the ingestion or infusion of a composition including beta-alanine, beta-alanine and creatine, or beta-alanine, L-histidine and creatine, or active derivatives thereof.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: January 20, 2004
    Assignee: Natural Alternatives International
    Inventors: Roger Harris, Mark Dunnett
  • Patent number: RE45947
    Abstract: A method for increasing the synthesis and accumulation of beta-alanylhistidine dipeptides, with a simultaneous increase in the accumulation of creatine, in bodily tissues of humans and animals is described. This is accomplished by causing an increase in the blood plasma concentrations of beta-alanine and creatine, or the blood plasma concentrations of beta-alanine, L-histidine and creatine, by the ingestion or infusion of a composition including beta-alanine, beta-alanine and creatine, or beta-alanine, L-histidine and creatine, or active derivatives thereof.
    Type: Grant
    Filed: February 25, 2014
    Date of Patent: March 29, 2016
    Assignee: Natural Alternatives International, Inc.
    Inventors: Roger Harris, Mark Dunnett